Article
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
BMC infectious diseases - 6 Nov 2017
Pang Yu, Zhu Damian, Zheng Huiwen, Shen Jing, Hu Yan, Liu Jie, Zhao Yanlin
Abstract excerpt
BACKGROUND: Pyrazinamide (PZA) plays a unique role in the treatment for multidrug-resistant tuberculosis (MDR-TB) in both first- and second-line regimens. The aim of this study was to investigate the prevalence and molecular characterization of PZA resistance among MDR-TB isolates collected in Chongqing municipality. METHODS: A total of 133 MDR-TB isolates were collected from the smear-positive tuberculosis...
Topics
Join the communities discussing this publication.
